Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1-Reference-Cited by-同舟云学术

Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1

Published:2017-12-01 Issue:5 Volume:32 Page:e176-e177
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Thomas S.¹²,Laino A.¹²,Sturm R.¹,Nufer K.¹,Lambie D.²³,Shepherd B.²,Atkinson V.⁴,Adams L.¹,Soyer H.P.¹²,Schaider H.¹

Affiliation:

1. Dermatology Research Centre; The University of Queensland Diamantina Institute; Translational Research Institute; The University of Queensland; Brisbane QLD Australia

2. Department of Dermatology; Princess Alexandra Hospital; Brisbane QLD Australia

3. IQ Pathology; Brisbane QLD Australia

4. Department of Medical Oncology; Princess Alexandra Hospital; Brisbane QLD Australia

Funder

Centre of Research Excellence for the Study of Naevi

National Health and Medical Research Council

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14678/fullpdf

Reference10 articles.

1. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial;Robert;Lancet,2014

2. A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma;Wolner;Br J Dermatol,2017

3. Complete regression of primary malignant melanoma;Emanuel;Am J Dermatopathol,2008

4. Metastatic melanoma with spontaneous complete regression of a thick primary lesion;Khosravi;JAAD Case Rep,2016

5. Complete regression of primary cutaneous malignant melanoma;Menzies;Arch Surg,1997

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nivolumab-induced poliosis restricted to a tattoo: A coincidental association?;Annales de Dermatologie et de Vénéréologie;2023-09

2. Widespread vitiligo and poliosis following ipilimumab–nivolumab combination therapy;Journal of Oncology Pharmacy Practice;2023-02-14

3. Poliosis Is Associated with Response to Checkpoint-Inhibitor Therapy: A Case Report of Two Patients with Multifocal Metastatic Melanoma;Immuno;2022-03-31

4. Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional study;JAAD International;2021-12

5. Development of Poliosis Following Checkpoint Inhibitor Treatment for Cutaneous Melanoma;Ophthalmic Plastic & Reconstructive Surgery;2019-09